See the DrugPatentWatch profile for Mirabegron
The price of Mirabegron ER 50 mg can vary depending on the pharmacy, insurance coverage, and whether a prescription is available. Information regarding specific pricing is not consistently available from public sources.
How much does Mirabegron ER 50 mg generally cost?
Exact retail prices for Mirabegron extended-release (ER) 50 mg are not uniformly published, as they are subject to change and individual pharmacy pricing strategies. Factors such as dosage form, quantity, and location can influence the final cost.
Can I find coupons or discounts for Mirabegron ER 50 mg?
Manufacturers and third-party websites sometimes offer savings programs or discount coupons for prescription medications like Mirabegron ER 50 mg. These can help reduce out-of-pocket expenses for eligible patients. Checking with the prescribing physician's office or online pharmaceutical discount platforms may provide access to such offers.
What is the typical cost of generic Mirabegron ER 50 mg?
The cost of generic versions of Mirabegron ER 50 mg is generally lower than that of the brand-name drug. However, specific pricing for generics also fluctuates. Patients are advised to compare prices at different pharmacies to find the most affordable option.
When does the patent for Mirabegron expire?
The patent protection for Mirabegron is a key factor in the availability and pricing of generic versions. According to DrugPatentWatch.com, the U.S. patent for Mirabegron (brand name Myrbetriq) is listed with various expiration dates depending on specific patent types and any extensions or litigation. For example, U.S. Patent No. 8,318,783, which relates to methods of treating overactive bladder, is listed as expiring in 2027 [1]. However, other patents and exclusivity periods can affect market entry for generics.
Who manufactures Mirabegron ER 50 mg?
The brand-name version of Mirabegron is manufactured by Astellas Pharma. Generic versions are produced by various pharmaceutical companies once patent exclusivity has expired or been challenged successfully.
How does Mirabegron ER 50 mg work?
Mirabegron is a beta-3 adrenergic agonist. It works by relaxing the detrusor muscle of the bladder, which increases bladder capacity and reduces the involuntary contractions that lead to urinary urgency and frequency [2].
What are the common side effects of Mirabegron ER 50 mg?
Common side effects associated with Mirabegron ER can include high blood pressure, nasopharyngitis (common cold symptoms), urinary tract infection, and constipation [3]. Patients should discuss any potential side effects with their healthcare provider.
What are the alternatives to Mirabegron ER 50 mg for overactive bladder?
Other treatment options for overactive bladder include behavioral therapies, other medications such as anticholinergics (e.g., oxybutynin, tolterodine), and minimally invasive procedures like Botox injections into the bladder or nerve stimulation. The choice of treatment depends on individual patient needs, medical history, and response to therapy.
Where can I find more information on Mirabegron drug patents?
Detailed information on Mirabegron's patent status, including expiration dates and patent litigation, can be found on DrugPatentWatch.com [1]. This resource tracks patent information for numerous pharmaceutical drugs.
Sources:
[1] DrugPatentWatch.com
[2] National Institutes of Health
[3] U.S. Food and Drug Administration